A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer by Yang James C, Haworth Leah, Sherry Richard M, Hwu Patrick, Schwartzentruber Douglas J, Topalian Suzanne L, Steinberg Seth M, Chen Helen X, Rosenberg Steven A in The New England journal of medicine (2003).

[PMID: 12890841] PubMed


Discussed In Paper


Dosing Information

No dosing information annotated.